PEAK6 LLC

Position in PACB — Pacific Biosciences Of California, Inc.

CIK 1389958 AUSTIN, TX

Back to PACB Full portfolio

Position in PACB

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$933,327

+$142,618 QoQ

Shares Held

555,552

-7.3% QoQ

Ownership

0.179%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#43

of 221 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in PACB Over Time

Shares Held

Position Value (USD)

Derivatives in PACB

reported options exposure · as of Dec 31, 2025

CallValue

$2,992,000

CallShares

1,600,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

PEAK6 LLC holds $31,018,471 across 4 Medical Devices names. PACB ranks #2 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	683,808	$29,184,925
2	PACB	Pacific Biosciences Of California, Inc. This page	555,552	$933,327
3	PEN	Penumbra Inc	2,600	$820,950
4	NXL	Nexalin Technology, Inc.	240,210	$79,269

All Filings in PACB

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$933,327	555,552	-7.3%	Shares	Defined	2026-08-13
2026-03-31	$790,709	599,022	-32.7%	Shares	Defined	2026-05-14
2025-12-31	$2,992,000	1,600,000	+166.7%	Call	Defined	2026-03-12
2025-09-30	$768,000	600,000	0.0%	Call	Defined	2026-03-31
2025-09-30	$1,139,965	890,598	-10.9%	Shares	Defined	2026-03-31
2025-06-30	$1,240,000	1,000,000	—	Shares	Defined	2026-03-26
2025-06-30	$744,000	600,000	—	Call	Defined	2026-03-26
No filing history on record for this holder in this stock.